At a glance
ClinicalIndex Comparison RecordN/ACompleted· 37 enrolled
Drug / intervention
AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric IOLdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Retrospective / Prospective Clinical Study of AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric Intraocular Lenses
In Brief
A clinical study evaluating AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric IOL for Cataract and 2 related conditions. Completed, enrolled 37 participants.
Detailed Summary
The purpose of this study is to characterize the safety and effectiveness of the ACRYSOF IQ ReSTOR +2.5 diopter (D) Multifocal Toric Intraocular Lens (IOL) in subjects at least 3 months and no more than 14 months after IOL implantation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract, Presbyopia, Corneal Astigmatism
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 2014
Enrollment StartJul 2014
Primary CompletionAug 2014
TodayJul 2026
First PostedJun 27, 2014
Enrollment StartJul 21, 2014
Primary CompletionAug 22, 2014
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 12.0 years ago
Interventions
AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric IOLdevice
Multifocal IOL with extended secondary focal point and astigmatism correction implanted for long-term use over the lifetime of the cataract patient